The Big Impact of Skinny Labels: What the Supreme Court’s Decision in Hikma v. Amarin May Mean for Patent Strategy

The Supreme Court will decide if a generic drug maker that omits patented uses from its label can still be liable for patent infringement based on marketing. The ruling could impact pharmaceutical ...
Medscape

Drug Labels Often Neglect to Inform About Obesity Dosing

Obesity can alter the action of many types of medications in ways affecting safety and/or efficacy, but this often isn’t mentioned in the labels. Experts in obesity and pharmacology are trying to ...
Becker's Hospital Review

Over Half of Neonate Drug Labels Lack Sufficient Information

Researchers looking at neonate drug label changes following recent legislation found only 46 percent of neonatal labeling changes indicated the safety and effectiveness of the drug, according to a ...
Managing Intellectual Property

Patent infringement and skinny labels: Taiwan judgments on generic drug indication carve-outs

Bruce Huang of Saint Island International Patent & Law Offices explains how the Intellectual Property and Commercial Court ...
Healio

Program delabels other drug allergies during COVID-19 vaccine evaluations

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Most drug allergy labels persist due to limited access ...